AT340069B - Verfahren zur herstellung von neuen prostaglandinen - Google Patents

Verfahren zur herstellung von neuen prostaglandinen

Info

Publication number
AT340069B
AT340069B AT504873A AT504873A AT340069B AT 340069 B AT340069 B AT 340069B AT 504873 A AT504873 A AT 504873A AT 504873 A AT504873 A AT 504873A AT 340069 B AT340069 B AT 340069B
Authority
AT
Austria
Prior art keywords
prostaglandines
manufacturing new
manufacturing
new
new prostaglandines
Prior art date
Application number
AT504873A
Other languages
German (de)
English (en)
Other versions
ATA504873A (de
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT786274A priority Critical patent/AT331261B/de
Publication of ATA504873A publication Critical patent/ATA504873A/de
Application granted granted Critical
Publication of AT340069B publication Critical patent/AT340069B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
AT504873A 1972-06-07 1973-06-07 Verfahren zur herstellung von neuen prostaglandinen AT340069B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT786274A AT331261B (de) 1972-06-07 1974-09-30 Verfahren zur herstellung von neuen verbindungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (2)

Publication Number Publication Date
ATA504873A ATA504873A (de) 1977-03-15
AT340069B true AT340069B (de) 1977-11-25

Family

ID=22989486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT504873A AT340069B (de) 1972-06-07 1973-06-07 Verfahren zur herstellung von neuen prostaglandinen

Country Status (24)

Country Link
JP (2) JPS5715591B2 (es)
AR (1) AR207434A1 (es)
AT (1) AT340069B (es)
BE (1) BE800580A (es)
CA (1) CA985280A (es)
CH (3) CH591511A5 (es)
CS (1) CS200166B2 (es)
DD (2) DD115687A5 (es)
DE (1) DE2329092A1 (es)
ES (3) ES415611A1 (es)
FI (1) FI58327C (es)
FR (2) FR2187344B1 (es)
GB (2) GB1439512A (es)
HU (3) HU170200B (es)
IE (1) IE38058B1 (es)
IL (2) IL42385A (es)
IN (1) IN138966B (es)
LU (1) LU67754A1 (es)
NL (2) NL160814C (es)
NO (2) NO146538C (es)
PH (2) PH14204A (es)
SE (3) SE415883B (es)
YU (1) YU36498B (es)
ZA (1) ZA733763B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
CA985280A (en) 1976-03-09
IN138966B (es) 1976-04-17
JPS5715591B2 (es) 1982-03-31
FR2273814B1 (es) 1977-07-08
DD115687A5 (es) 1975-10-12
AU5643173A (en) 1974-12-05
PH14204A (en) 1981-04-01
ES415611A1 (es) 1976-07-16
ZA733763B (en) 1974-04-24
CH605887A5 (es) 1978-10-13
SE418744B (sv) 1981-06-22
BE800580A (fr) 1973-12-07
DD109211A5 (es) 1974-10-20
JPS5731692A (en) 1982-02-20
NL7307867A (es) 1973-12-11
SE415883B (sv) 1980-11-10
ATA504873A (de) 1977-03-15
FI58327C (fi) 1981-01-12
YU152673A (en) 1982-02-25
IL42385A0 (en) 1973-07-30
CS200166B2 (en) 1980-08-29
IE38058L (en) 1973-12-07
NO146538C (no) 1982-10-20
GB1439512A (en) 1976-06-16
CH593929A5 (es) 1977-12-30
NL160814C (nl) 1979-12-17
HU170487B (es) 1977-06-28
IE38058B1 (en) 1977-12-21
FR2187344A1 (es) 1974-01-18
HU170200B (es) 1977-04-28
SE7608225L (sv) 1976-07-19
ES430416A1 (es) 1976-10-16
FI58327B (fi) 1980-09-30
IL51525A0 (en) 1977-04-29
NL7812163A (nl) 1979-04-27
FR2187344B1 (es) 1977-10-28
HU170491B (es) 1977-06-28
JPS4954350A (es) 1974-05-27
IL42385A (en) 1979-10-31
LU67754A1 (es) 1973-12-14
DE2329092A1 (de) 1974-01-03
GB1439511A (en) 1976-06-16
SE7608224L (sv) 1976-07-19
AR207434A1 (es) 1976-10-08
NO740850L (no) 1973-12-10
PH13092A (en) 1979-11-27
ES430417A1 (es) 1977-03-01
FR2273814A1 (fr) 1976-01-02
NO142784C (no) 1980-10-15
NO142784B (no) 1980-07-07
CH591511A5 (es) 1977-09-30
NO146538B (no) 1982-07-12
NL160814B (nl) 1979-07-16
YU36498B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
AT322838B (de) Verfahren zur herstellung von poly-alfa-olefinen
AT367033B (de) Verfahren zur herstellung von neuen prostaglandinen
ATA770674A (de) Verfahren zur herstellung von neuen penicillinen
AT341640B (de) Verfahren zur herstellung von dickstellengarnen
AT325767B (de) Verfahren zur herstellung von neuen penicillinen
AT325774B (de) Verfahren zur herstellung von neuen penicillinen
AT329177B (de) Verfahren zur herstellung von neuen penicillinen
AT328420B (de) Verfahren zur herstellung von hydrazonen
AT326268B (de) Verfahren zur herstellung von neuen penicillinen
AT340069B (de) Verfahren zur herstellung von neuen prostaglandinen
AT324561B (de) Verfahren zur herstellung von neuen penicillinen
AT330957B (de) Verfahren zur herstellung von neuen penicillinen
AT332972B (de) Verfahren zur herstellung von neuen penicillinen
AT326821B (de) Verfahren zur herstellung von neuen penicillinen
AT327413B (de) Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen
AT329176B (de) Verfahren zur herstellung von neuen penicillinen
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT329183B (de) Verfahren zur herstellung von neuen penicillinen
AT327385B (de) Verfahren zur herstellung von neuen penicillinen
AT330356B (de) Verfahren zur herstellung von neuen penicillinen
ATA967374A (de) Verfahren zur herstellung von neuen oxaprostaglandinen
AT331971B (de) Verfahren zur herstellung von neuen 3-monoestern von rosamicin
AT324564B (de) Verfahren zur herstellung von neuen monoestern von alpha-carboxypenicillinen
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee